Show simple item record

dc.contributor.author Cotorobai, lulia
dc.date.accessioned 2021-11-15T10:58:26Z
dc.date.available 2021-11-15T10:58:26Z
dc.date.issued 2014
dc.identifier.citation COTOROBAI, lulia. The treatment of pain to oncological patients. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, pp. 114-115. en_US
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/18490
dc.description State University of Medicine and Pharmacy “Nicolae Testemitanu”, Department of Hematology, Oncology and Therapy Campaign, Discipline of Oncology, Chisinau, Republic of Moldova en_US
dc.description.abstract Introduction: Cancer pain may be due to the disease itself or can result from the treatment, including surgery, radiation therapy and chemotherapy. Although usually occurs relatively late in the natural history of the disease, the most common symptom is pain in the cancer present in 30- 40% of patients at diagnosis from 40-70% to 70-90% at baseline and during phase terminals. The prevalence of pain depends on the type of tumor, ranging from 52% in patients with lung cancers and up to 5% in patients with leukemia. Purpose and Objectives: The evaluation and appreciation of chronic pain in oncological pathology Materials and methods: The study conducted on a group of 50 patients from October 2013 to January using the Brief Pain Inventory (BPI). Results: The group studied consisted of women 44%, men 56%. BPI is a numerical scale of 0-10 assessing the degree of pain interference with the normal activities of the patient which it applies, to which is added information on the gradation of the pain, the pain at the time of examination. Starting from the order established after evaluation of maximum intensity of the pain score 6-30%, followed by the score 8-15%, scores 9 and 10 - 10-12%. When assessing the minimum level of pain intensity score of 2 to 23% and score 4 to 20 %, which ranks the most frequently encountered in patients investigated. Usual level of pain intensity score highlights the prevalence of 6 and 8 with 20%, followed by the score 5 to 18%, the other scores were determined from a minimum of patients. Depending on the type of treatment: 79% were receiving chemotherapy, chemo-radiotherapeutic treatment 5%, hormone therapy 2% and unspecified 14%. According to the step by step antalgic treatment, elaborated by WHO: analgesic stage administered -7% stage I, stage II- 23% and stage III - 70 %. Conclusion: Analyzing all the features of chronic pain by using the BPI questionnaire in the study of cancer patients, we determined that although in theory the current therapeutic methods and applying rational (W HO principles) would allow excellent results in almost 95% of patients, but cancer pain remains untreated satisfactory in many situations. en_US
dc.language.iso en en_US
dc.publisher Ministry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association en_US
dc.relation.ispartof MedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldova en_US
dc.subject Pain en_US
dc.subject score en_US
dc.title The treatment of pain to oncological patients en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

  • MedEspera 2014
    The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics